Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues: |
| Americas | | 6,602.0 | 6,732.0 | 6,666.0 | 6,592.0 | 6,471.0 | 6,316.0 | 6,255.0 |
| EMEA | | 3,468.0 | 3,513.0 | 3,552.0 | 3,352.0 | 3,293.0 | 3,179.0 | 3,195.0 |
| APAC | | 2,738.0 | 2,782.0 | 2,803.0 | 2,759.0 | 2,685.0 | 2,574.0 | 2,475.0 |
| Other | | 1,233.0 | 518.0 | | | | | |
| Total revenues | | 14,041.0 | 13,545.0 | 12,784.0 | 12,451.0 | 12,197.0 | 11,817.0 | 11,673.0 |
| Revenue growth [+] | | 15.1% | 14.6% | 9.5% | 8.0% | 6.9% | 2.5% | 2.7% |
| Americas | | 2.0% | 6.6% | 6.6% | 2.7% | 2.0% | -1.3% | -0.8% |
| EMEA | | 5.3% | 10.5% | 11.2% | 14.3% | 11.9% | 5.4% | 7.6% |
| APAC | | 2.0% | 8.1% | 13.3% | 15.3% | 15.0% | 10.6% | 7.6% |
| Medication Delivery | | 6.9% | 10.1% | 6.5% | 6.1% | 1.7% | -4.7% | -1.3% |
| Cost of goods sold | | 8,595.0 | 8,237.0 | 7,679.0 | 7,561.0 | 7,433.0 | 7,248.0 | 7,086.0 |
| Gross profit | | 5,446.0 | 5,308.0 | 5,105.0 | 4,890.0 | 4,764.0 | 4,569.0 | 4,587.0 |
| Gross margin | | 38.8% | 39.2% | 39.9% | 39.3% | 39.1% | 38.7% | 39.3% |
| Selling, general and administrative [+] | | 3,587.0 | 3,292.0 | 2,867.0 | 2,632.0 | 2,553.0 | 2,468.0 | 2,469.0 |
| Sales and marketing | | 2,702.0 | 2,407.0 | | 1,982.0 | 1,903.0 | 1,818.0 | |
| General and administrative | | | | 885.0 | | | | 650.0 |
| Research and development | | 565.0 | 556.0 | 534.0 | 531.0 | 525.0 | 503.0 | 521.0 |
| Other operating expenses | | -28.0 | -22.0 | | | -5.0 | | |
| EBITDA [+] | | 2,508.0 | 2,313.0 | 2,377.0 | 2,368.0 | | 2,439.0 | 2,437.0 |
| EBITDA growth | | 7.6% | -5.2% | -2.5% | -7.8% | -9.6% | -5.6% | -4.5% |
| EBITDA margin | | 17.9% | 17.1% | 18.6% | 19.0% | 19.1% | 20.6% | 20.9% |
| Depreciation | | 609.0 | 380.0 | 370.0 | 380.0 | 394.0 | 607.0 | 601.0 |
| EBITA | | 1,899.0 | 1,933.0 | 2,007.0 | 1,988.0 | 1,936.0 | 1,832.0 | 1,836.0 |
| EBITA margin | | 13.5% | 14.3% | 15.7% | 16.0% | 15.9% | 15.5% | 15.7% |
| Amortization of intangibles | | 577.0 | 451.0 | 298.0 | 256.0 | 245.0 | 234.0 | 222.0 |
| EBIT [+] | | 1,322.0 | 1,482.0 | 1,709.0 | 1,732.0 | 1,691.0 | 1,598.0 | 1,614.0 |
| EBIT growth | | -21.8% | -7.3% | 5.9% | -0.9% | -5.0% | -11.0% | -8.9% |
| EBIT margin | | 9.4% | 10.9% | 13.4% | 13.9% | 13.9% | 13.5% | 13.8% |
| Non-recurring items | | | | | -1.0 | | | |
| Interest expense, net [+] | | 170.0 | 115.0 | 64.0 | 112.0 | 101.0 | 103.0 | 90.0 |
| Interest expense | | 359.0 | 307.0 | 256.0 | 240.0 | 228.0 | 231.0 | 224.0 |
| Interest income | | | 192.0 | 192.0 | 128.0 | 127.0 | 128.0 | 134.0 |
| Other income (expense), net [+] | | -106.0 | -148.0 | -169.0 | -217.0 | -221.0 | -229.0 | -234.0 |
| Other non-operating gains/losses | | 4.0 | | | -1.0 | -4.0 | -5.0 | -1.0 |
| Other | | 104.0 | 66.0 | 45.0 | 211.0 | 207.0 | 195.0 | 190.0 |
| Pre-tax income | | 1,047.0 | 1,220.0 | 1,477.0 | 1,404.0 | 1,368.0 | 1,265.0 | 1,292.0 |
| Income taxes | | 95.0 | 152.0 | 182.0 | 180.0 | 237.0 | 188.0 | 182.0 |
| Tax rate | | 9.1% | 12.5% | 12.3% | | 17.3% | 14.9% | 14.1% |
| Minority interest | | 11.0 | 11.0 | 11.0 | 10.0 | 11.0 | 9.0 | 8.0 |
| Earnings from continuing ops | | 941.0 | 1,057.0 | 1,284.0 | 1,214.0 | 1,120.0 | 1,068.0 | 1,102.0 |
| Earnings from discontinued ops | | 70.0 | | | | | | |
| Net income | | 1,011.0 | 1,057.0 | 1,284.0 | 1,214.0 | 1,120.0 | 1,068.0 | 1,102.0 |
| Net margin | | 7.2% | 7.8% | 10.0% | 9.8% | 9.2% | 9.0% | 9.4% |
| |
| Basic EPS [+] | | $1.87 | $2.11 | $2.56 | $2.41 | $2.21 | $2.10 | $2.17 |
| Growth | | -15.2% | 0.3% | 18.0% | 34.5% | 21.7% | 7.9% | 10.4% |
| Diluted EPS [+] | | $1.85 | $2.08 | $2.53 | $2.38 | $2.18 | $2.07 | $2.13 |
| Growth | | -15.0% | 0.5% | 18.5% | 35.0% | 22.2% | 8.3% | 10.7% |
| |
| Dividends per share [+] | $0.00 | $1.13 | $1.12 | $1.09 | $1.05 | $1.02 | $0.98 | $0.96 |
| Growth | -100.0% | 11.3% | 14.3% | 13.6% | 12.9% | 12.2% | 11.4% | 12.4% |
| |
| Shares outstanding (basic) [+] | | 502.3 | 502.0 | 502.5 | 504.3 | 507.0 | 508.5 | 509.0 |
| Growth | | -0.9% | -1.3% | -1.3% | -0.9% | -0.4% | -0.1% | -0.3% |
| Shares outstanding (diluted) [+] | | 507.8 | 508.0 | 508.5 | 510.8 | 513.8 | 515.8 | 517.0 |
| Growth | | -1.2% | -1.5% | -1.6% | -1.3% | -0.8% | -0.5% | -0.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|